Osmolality, sodium, potassium, chloride, and bicarbonate

Osmolality and volume regulation Introduction Osmolality in plasma is related to the number of solutes (soluble particles) dissolved in a kg of plasma water, with a normal osmolality between 280 and 295 mOsm Measurement of serum osmolality is used to evaluate the body's regulation of water and sodium balance, while urine osmolality evaluates the kidney's ability to concentrate urine. In a steady state, our total body…

Phosphate physiology and clinical evaluation

Introduction Symptoms of phosphate depletion have been described through the years, from the times of the ancient Romans to observations by veterinarians on livestock. Phosphate compounds are in all cells and participate in numerous biochemical processes. Phosphate is a component of DNA and RNA, phospholipids, high-energy compounds such as ATP and creatine phosphate, and many coenzymes. When both phosphate depletion and hypophosphatemia are present, serious biochemical…

Magnesium physiology and clinical evaluation

Introduction In 1695, from well water in Epsom, England, Dr. Nehemiah Grew prepared Epsom salts, a name still given to magnesium sulfate. The biological significance of magnesium as a constituent of plants has been known since the 18th century, with magnesium ion an essential component of chlorophyll. Hypomagnesemia is observed in about 10% of hospitalized patients and especially critically ill patients who often have other coexisting…

Calcium physiology and clinical evaluation

Introduction and history In 1883, Sydney Ringer showed that calcium was essential for myocardial contraction ( ) . In 1934, Franklin McLean and Baird Hastings published a report in the Journal of Biological Chemistry showing that the ionized calcium concentration was proportional to the amplitude of frog heart contraction, whereas protein-bound and citrate-bound calcium had no effect ( ) . After many attempts to develop improved…

Disorders of oxygenation: hypoxemia and tissue hypoxia

Introduction Hypoxemia, a decreased partial pressure of oxygen in the blood, is a commonly encountered clinical problem among patients with acute or chronic cardiopulmonary disorders. Accurately characterizing the cause and severity of hypoxemia in a timely manner can have significant implications for clinical management and patient prognosis. The blood gas measurements play an integral part in the evaluation of the hypoxemic patient, as does the understanding…

Interpreting blood gas results on venous, capillary, and umbilical cord blood

Physiologic differences between arterial and venous blood for blood gas and acid–base measurements More than any other analytes, p O 2 , p CO 2 , and pH change markedly from arterial to venous blood. While the pH apparently changes only slightly (i.e., 7.40 to 7.37 = 0.4% difference), the actual H ion concentration has a much greater relative change, going from 3.98 × 10 −8…

Physiologic mechanisms and diagnostic approach to acid–base disorders

Metabolic acidosis Metabolic acidosis is defined as a clinical process that leads to a decreased blood pH (acidemia) and a decreased HCO 3 level. It is caused by a gain of acidic compounds and/or loss of a base, usually bicarbonate. Electrolyte movements can also play a role in acid–base balance that are sometimes manifested as an increased anion gap. Physiologic mechanisms of metabolic acidosis ( )…

Transfusion Medicine and Cellular Therapy

Blood Collection In the United States, 14.2 million red blood cells and whole blood donations and approximately 2.4 million apheresis and whole blood–derived platelets were collected in 2013. Although whole blood donations are the primary method for the manufacturing of red blood cells (RBCs), plasma, and cryoprecipitate components, platelets are now predominantly collected by apheresis technology. Individual component manufacturing allows for the optimal storage conditions for…

Hemophilia

General Overview and Incidence Overview of Hemophilia The hemophilias are bleeding disorders caused by the absence or decrease of factor VIII in hemophilia A or factor IX in hemophilia B. Coagulation Factors VIII and IX (FVIII and FIX) are part of the coagulation cascade of secondary hemostasis. Classically, the coagulation cascade has two initial pathways leading to fibrin formation ( Fig. 18.1 ). These are the…

Infectious Processes in Blood and Bone Marrow

Viral Infections Certain viral infections can cause cytopathic changes in blood cells or changes in the maturation of blood cells. The nuclear or cytoplasmic inclusions of some viruses, particularly the herpesviruses, are visible by light microscopy. The most easily identified cytopathic changes are those of cytomegalovirus (CMV) ( Fig. 17.1 ). Nonspecific findings in bone marrow of CMV-infected patients may include myeloid and megakaryocytic suppression, hemophagocytosis,…

Posttransplant Lymphoproliferative Disorders and Immunodeficiency

General Overview and Incidence Incidence varies depending on the institution, patient population, allograph types, and immunosuppression regimes. Etiology/Histopathology Clinical settings causing immune dysfunctions, such as viral Epstein-Barr virus (EBV) infection, human viral immunodeficiency, autoimmune disease, and posttransplantation, can cause clonal B- and T-cell lymphoid proliferations, effacing and altering the normal histology architecture and causing symptoms and mass lesions. Clinical Presentation Fatigue Pain Mass lesions Ulcers Headache…

Childhood Hematopoietic Disorders

General Overview and Incidence Pediatric hematology/hematopathology spans the spectrum of benign, malignant, and neoplastic mimickers. Neoplastic lymphoid, myeloid, and histocytic neoplasms follow criteria in the updated World Health Organization (WHO) 2017 classification similar to adults. Examples of common entities or those related to the updated WHO 2017 classification are presented for illustrative purposes. Many of these entities are covered in more depth in Chapter 8, Chapter…

Myeloma and Related Conditions

General Overview and Incidence Multiple myeloma (MM) is a malignancy of clonal plasma cells and is part of a spectrum of plasma cells disorders encompassing the benign asymptomatic condition monoclonal gammopathy of unknown significance (MGUS), smoldering MM (SMM), symptomatic MM, and the more aggressive forms such as plasma cell leukemia with circulating myeloma cells in the peripheral blood ( Fig. 14.1 ). In 1850, Dr. Henry…

Indolent and Aggressive Mature T-Cell and Natural Killer–Cell Lymphomas

T-Cell and Natural Killer–Cell Neoplasms With Primarily Leukemic Involvement T-Cell Prolymphocytic Leukemia Overview and Incidence T-cell prolymphocytic leukemia (T-PLL) is an aggressive, mature T-cell malignancy affecting predominantly older adults and accounts for 2% of chronic leukemias. There is an approximate 3:1 male predominance. Patients with ataxia telangiectasia show an increased incidence of T-PLL. Etiology and Histopathology The peripheral blood and bone marrow demonstrate a proliferation of…

Indolent and Aggressive B-Cell Lymphoma

Introduction Non-Hodgkin B-cell lymphomas are the seventh most common malignant neoplasm and account for approximately 4% of all cancers, according to the American Cancer Society, with approximately 77,000 cases anticipated to be diagnosed annually in the United States, not including an additional 21,000 estimated cases of chronic lymphocytic leukemia ( ). B-cell neoplasms often mimic normal stages of B-cell maturation from lymphoblasts generated in the…

Hodgkin Lymphoma

General Overview and Incidence Definition of Hodgkin lymphoma (HL): lymphoid neoplasm affecting lymph nodes; paucity of neoplastic cells with rich inflammatory background Classic Hodgkin lymphoma (cHL) 90% to 95% of cases Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) 5% to 10% of cases , Epidemiology 2.5 to 3 per 100,000 per year with higher incidence in men In 2014, estimated 204,065 people with HL in the United States…

B-Cell Chronic Lymphoid Leukemias

In healthy adults and older children, the majority of circulating lymphocytes in the blood are T cells (approximately 70% of lymphocytes) with fewer B cells (25%) and natural killer (NK) cells (5%). However, at birth this proportion is reversed, with B cells outnumbering T cells by a ratio of 2:1. The normal absolute lymphocyte count and normal relative percentage of lymphocytes also vary with age. In…

Precursor Lymphoid Neoplasms

General Overview and Incidence Precursor lymphoid neoplasms or acute lymphoblastic leukemia (ALL) is the second most common leukemia affecting adults with about 1.6 per 100,000 and 6500 cases per year in the United States. In 2018, an estimated 5960 new cases were diagnosed, with 1470 deaths caused by ALL. , ALL occurs in both children and adults with the highest rates between the ages of 3…

Acute Myeloid Leukemia

A Brief Overview of Acute Myeloid Leukemia Acute myeloid leukemia (AML) is understood to be the product of genetic and epigenetic changes within a multipotent myeloid stem/progenitor cell that generate and amplify a clone capable of differentiation arrest and uncontrolled proliferation. This clone, completely unmoored from the genetic machinery and stromal signaling that may normally regulate its maturation and expansion, propagates unceasingly, suffocating the bone marrow…